nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—TUBB4B—bone cancer	0.166	0.516	CbGaD
Vincristine—TUBB2A—bone cancer	0.138	0.428	CbGaD
Vincristine—muscle cancer—bone cancer	0.106	0.289	CtDrD
Vincristine—kidney cancer—bone cancer	0.0886	0.242	CtDrD
Vincristine—peripheral nervous system neoplasm—bone cancer	0.0877	0.239	CtDrD
Vincristine—sarcoma—bone cancer	0.0844	0.23	CtDrD
Vincristine—RALBP1—Doxorubicin—bone cancer	0.049	0.225	CbGbCtD
Vincristine—CYP3A4—bone cancer	0.018	0.056	CbGaD
Vincristine—ABCC10—Doxorubicin—bone cancer	0.018	0.0826	CbGbCtD
Vincristine—ABCC10—Methotrexate—bone cancer	0.0174	0.08	CbGbCtD
Vincristine—ABCC3—Cisplatin—bone cancer	0.0169	0.0775	CbGbCtD
Vincristine—ABCC1—Epirubicin—bone cancer	0.0131	0.06	CbGbCtD
Vincristine—ABCC3—Doxorubicin—bone cancer	0.0113	0.0519	CbGbCtD
Vincristine—ABCC3—Methotrexate—bone cancer	0.011	0.0503	CbGbCtD
Vincristine—ABCB11—Doxorubicin—bone cancer	0.00977	0.0449	CbGbCtD
Vincristine—ABCC2—Carboplatin—bone cancer	0.00897	0.0412	CbGbCtD
Vincristine—ABCG2—Carboplatin—bone cancer	0.00811	0.0373	CbGbCtD
Vincristine—ABCC2—Cisplatin—bone cancer	0.00767	0.0352	CbGbCtD
Vincristine—ABCC1—Doxorubicin—bone cancer	0.00694	0.0319	CbGbCtD
Vincristine—ABCG2—Cisplatin—bone cancer	0.00693	0.0318	CbGbCtD
Vincristine—ABCC1—Methotrexate—bone cancer	0.00673	0.0309	CbGbCtD
Vincristine—ABCC2—Doxorubicin—bone cancer	0.00514	0.0236	CbGbCtD
Vincristine—ABCC2—Methotrexate—bone cancer	0.00498	0.0229	CbGbCtD
Vincristine—ABCG2—Doxorubicin—bone cancer	0.00465	0.0213	CbGbCtD
Vincristine—ABCG2—Methotrexate—bone cancer	0.0045	0.0207	CbGbCtD
Vincristine—ABCB1—Cisplatin—bone cancer	0.0025	0.0115	CbGbCtD
Vincristine—ABCB1—Doxorubicin—bone cancer	0.00168	0.00769	CbGbCtD
Vincristine—ABCB1—Methotrexate—bone cancer	0.00162	0.00745	CbGbCtD
Vincristine—CYP3A4—Doxorubicin—bone cancer	0.001	0.00461	CbGbCtD
Vincristine—Vinorelbine—TUBB4B—bone cancer	0.000714	0.241	CrCbGaD
Vincristine—Vinorelbine—TUBB2A—bone cancer	0.000591	0.2	CrCbGaD
Vincristine—Vinblastine—TUBB4B—bone cancer	0.00055	0.186	CrCbGaD
Vincristine—Vinblastine—TUBB2A—bone cancer	0.000456	0.154	CrCbGaD
Vincristine—Vinblastine—JUN—bone cancer	0.000354	0.12	CrCbGaD
Vincristine—Febrile neutropenia—Doxorubicin—bone cancer	0.00017	0.00516	CcSEcCtD
Vincristine—Bone marrow depression—Epirubicin—bone cancer	0.000164	0.00497	CcSEcCtD
Vincristine—Paralysis—Epirubicin—bone cancer	0.000159	0.00483	CcSEcCtD
Vincristine—Vindesine—CYP3A4—bone cancer	0.000159	0.0535	CrCbGaD
Vincristine—Hyponatraemia—Cisplatin—bone cancer	0.000157	0.00476	CcSEcCtD
Vincristine—Ileus—Epirubicin—bone cancer	0.000156	0.00474	CcSEcCtD
Vincristine—Nystagmus—Epirubicin—bone cancer	0.000155	0.00469	CcSEcCtD
Vincristine—Bone marrow depression—Doxorubicin—bone cancer	0.000152	0.0046	CcSEcCtD
Vincristine—Neuritis—Epirubicin—bone cancer	0.000148	0.00449	CcSEcCtD
Vincristine—Paralysis—Doxorubicin—bone cancer	0.000147	0.00446	CcSEcCtD
Vincristine—Dehydration—Cisplatin—bone cancer	0.000146	0.00441	CcSEcCtD
Vincristine—Ileus—Doxorubicin—bone cancer	0.000145	0.00438	CcSEcCtD
Vincristine—Nystagmus—Doxorubicin—bone cancer	0.000143	0.00434	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000141	0.00427	CcSEcCtD
Vincristine—Neuritis—Doxorubicin—bone cancer	0.000137	0.00415	CcSEcCtD
Vincristine—Extravasation—Methotrexate—bone cancer	0.000136	0.00411	CcSEcCtD
Vincristine—Pancytopenia—Cisplatin—bone cancer	0.000128	0.00389	CcSEcCtD
Vincristine—Hyperuricaemia—Methotrexate—bone cancer	0.000128	0.00386	CcSEcCtD
Vincristine—Extravasation—Epirubicin—bone cancer	0.000127	0.00384	CcSEcCtD
Vincristine—Respiratory failure—Methotrexate—bone cancer	0.000121	0.00365	CcSEcCtD
Vincristine—Blood uric acid increased—Methotrexate—bone cancer	0.000121	0.00365	CcSEcCtD
Vincristine—Hyperuricaemia—Epirubicin—bone cancer	0.000119	0.00361	CcSEcCtD
Vincristine—Acute coronary syndrome—Cisplatin—bone cancer	0.000119	0.0036	CcSEcCtD
Vincristine—Myocardial infarction—Cisplatin—bone cancer	0.000118	0.00358	CcSEcCtD
Vincristine—Neuropathy peripheral—Cisplatin—bone cancer	0.000118	0.00358	CcSEcCtD
Vincristine—Stomatitis—Cisplatin—bone cancer	0.000118	0.00356	CcSEcCtD
Vincristine—Extravasation—Doxorubicin—bone cancer	0.000117	0.00356	CcSEcCtD
Vincristine—Bone pain—Epirubicin—bone cancer	0.000116	0.0035	CcSEcCtD
Vincristine—Gait disturbance—Epirubicin—bone cancer	0.000113	0.00343	CcSEcCtD
Vincristine—Blood uric acid increased—Epirubicin—bone cancer	0.000113	0.00341	CcSEcCtD
Vincristine—Musculoskeletal pain—Epirubicin—bone cancer	0.000112	0.00339	CcSEcCtD
Vincristine—Hyperuricaemia—Doxorubicin—bone cancer	0.00011	0.00334	CcSEcCtD
Vincristine—Coma—Methotrexate—bone cancer	0.000108	0.00327	CcSEcCtD
Vincristine—Urine output increased—Methotrexate—bone cancer	0.000107	0.00324	CcSEcCtD
Vincristine—Mouth ulceration—Methotrexate—bone cancer	0.000107	0.00324	CcSEcCtD
Vincristine—Bone pain—Doxorubicin—bone cancer	0.000107	0.00324	CcSEcCtD
Vincristine—Urinary tract disorder—Cisplatin—bone cancer	0.000107	0.00324	CcSEcCtD
Vincristine—Connective tissue disorder—Cisplatin—bone cancer	0.000106	0.00322	CcSEcCtD
Vincristine—Urethral disorder—Cisplatin—bone cancer	0.000106	0.00321	CcSEcCtD
Vincristine—Gait disturbance—Doxorubicin—bone cancer	0.000105	0.00318	CcSEcCtD
Vincristine—Blood uric acid increased—Doxorubicin—bone cancer	0.000104	0.00316	CcSEcCtD
Vincristine—Neuropathy—Epirubicin—bone cancer	0.000104	0.00315	CcSEcCtD
Vincristine—Musculoskeletal pain—Doxorubicin—bone cancer	0.000104	0.00314	CcSEcCtD
Vincristine—Coma—Epirubicin—bone cancer	0.000101	0.00306	CcSEcCtD
Vincristine—Cardiac disorder—Cisplatin—bone cancer	0.000101	0.00304	CcSEcCtD
Vincristine—Mouth ulceration—Epirubicin—bone cancer	0.0001	0.00303	CcSEcCtD
Vincristine—Polyuria—Methotrexate—bone cancer	9.78e-05	0.00296	CcSEcCtD
Vincristine—Mediastinal disorder—Cisplatin—bone cancer	9.76e-05	0.00295	CcSEcCtD
Vincristine—Neuropathy—Doxorubicin—bone cancer	9.62e-05	0.00291	CcSEcCtD
Vincristine—Alopecia—Cisplatin—bone cancer	9.57e-05	0.0029	CcSEcCtD
Vincristine—Hepatic failure—Methotrexate—bone cancer	9.56e-05	0.00289	CcSEcCtD
Vincristine—Coma—Doxorubicin—bone cancer	9.36e-05	0.00283	CcSEcCtD
Vincristine—Mouth ulceration—Doxorubicin—bone cancer	9.26e-05	0.0028	CcSEcCtD
Vincristine—Hepatic failure—Epirubicin—bone cancer	8.95e-05	0.00271	CcSEcCtD
Vincristine—Anaemia—Cisplatin—bone cancer	8.71e-05	0.00264	CcSEcCtD
Vincristine—Leukopenia—Cisplatin—bone cancer	8.44e-05	0.00255	CcSEcCtD
Vincristine—Hepatic failure—Doxorubicin—bone cancer	8.28e-05	0.00251	CcSEcCtD
Vincristine—Convulsion—Cisplatin—bone cancer	8.17e-05	0.00247	CcSEcCtD
Vincristine—Ataxia—Methotrexate—bone cancer	8.08e-05	0.00245	CcSEcCtD
Vincristine—Hyponatraemia—Epirubicin—bone cancer	8.07e-05	0.00244	CcSEcCtD
Vincristine—Pain in extremity—Epirubicin—bone cancer	8.04e-05	0.00243	CcSEcCtD
Vincristine—Myalgia—Cisplatin—bone cancer	8.03e-05	0.00243	CcSEcCtD
Vincristine—Vinorelbine—CYP3A4—bone cancer	7.74e-05	0.0261	CrCbGaD
Vincristine—Anaphylactic shock—Cisplatin—bone cancer	7.69e-05	0.00233	CcSEcCtD
Vincristine—Oedema—Cisplatin—bone cancer	7.69e-05	0.00233	CcSEcCtD
Vincristine—Cardiac arrest—Epirubicin—bone cancer	7.64e-05	0.00231	CcSEcCtD
Vincristine—Infection—Cisplatin—bone cancer	7.64e-05	0.00231	CcSEcCtD
Vincristine—Ataxia—Epirubicin—bone cancer	7.56e-05	0.00229	CcSEcCtD
Vincristine—Nervous system disorder—Cisplatin—bone cancer	7.55e-05	0.00228	CcSEcCtD
Vincristine—Thrombocytopenia—Cisplatin—bone cancer	7.53e-05	0.00228	CcSEcCtD
Vincristine—Dehydration—Epirubicin—bone cancer	7.48e-05	0.00226	CcSEcCtD
Vincristine—Hyponatraemia—Doxorubicin—bone cancer	7.47e-05	0.00226	CcSEcCtD
Vincristine—Pain in extremity—Doxorubicin—bone cancer	7.44e-05	0.00225	CcSEcCtD
Vincristine—Hyperhidrosis—Cisplatin—bone cancer	7.44e-05	0.00225	CcSEcCtD
Vincristine—Anorexia—Cisplatin—bone cancer	7.33e-05	0.00222	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Epirubicin—bone cancer	7.24e-05	0.00219	CcSEcCtD
Vincristine—Hypotension—Cisplatin—bone cancer	7.19e-05	0.00218	CcSEcCtD
Vincristine—Muscular weakness—Epirubicin—bone cancer	7.09e-05	0.00215	CcSEcCtD
Vincristine—Cardiac arrest—Doxorubicin—bone cancer	7.07e-05	0.00214	CcSEcCtD
Vincristine—Pancytopenia—Methotrexate—bone cancer	7.05e-05	0.00213	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Cisplatin—bone cancer	7.01e-05	0.00212	CcSEcCtD
Vincristine—Ataxia—Doxorubicin—bone cancer	6.99e-05	0.00212	CcSEcCtD
Vincristine—Neutropenia—Methotrexate—bone cancer	6.94e-05	0.0021	CcSEcCtD
Vincristine—Dysuria—Methotrexate—bone cancer	6.94e-05	0.0021	CcSEcCtD
Vincristine—Dehydration—Doxorubicin—bone cancer	6.92e-05	0.00209	CcSEcCtD
Vincristine—Paraesthesia—Cisplatin—bone cancer	6.91e-05	0.00209	CcSEcCtD
Vincristine—Erectile dysfunction—Methotrexate—bone cancer	6.84e-05	0.00207	CcSEcCtD
Vincristine—Photosensitivity reaction—Methotrexate—bone cancer	6.78e-05	0.00205	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	6.7e-05	0.00203	CcSEcCtD
Vincristine—Decreased appetite—Cisplatin—bone cancer	6.69e-05	0.00202	CcSEcCtD
Vincristine—Pneumonia—Methotrexate—bone cancer	6.66e-05	0.00202	CcSEcCtD
Vincristine—Gastrointestinal disorder—Cisplatin—bone cancer	6.64e-05	0.00201	CcSEcCtD
Vincristine—Depression—Methotrexate—bone cancer	6.6e-05	0.002	CcSEcCtD
Vincristine—Pancytopenia—Epirubicin—bone cancer	6.6e-05	0.002	CcSEcCtD
Vincristine—Pain—Cisplatin—bone cancer	6.58e-05	0.00199	CcSEcCtD
Vincristine—Muscular weakness—Doxorubicin—bone cancer	6.56e-05	0.00199	CcSEcCtD
Vincristine—Dysuria—Epirubicin—bone cancer	6.5e-05	0.00197	CcSEcCtD
Vincristine—Neutropenia—Epirubicin—bone cancer	6.5e-05	0.00197	CcSEcCtD
Vincristine—Stomatitis—Methotrexate—bone cancer	6.45e-05	0.00195	CcSEcCtD
Vincristine—Sweating—Methotrexate—bone cancer	6.35e-05	0.00192	CcSEcCtD
Vincristine—Photosensitivity reaction—Epirubicin—bone cancer	6.34e-05	0.00192	CcSEcCtD
Vincristine—Weight decreased—Epirubicin—bone cancer	6.29e-05	0.0019	CcSEcCtD
Vincristine—Pneumonia—Epirubicin—bone cancer	6.23e-05	0.00189	CcSEcCtD
Vincristine—Pancytopenia—Doxorubicin—bone cancer	6.11e-05	0.00185	CcSEcCtD
Vincristine—Body temperature increased—Cisplatin—bone cancer	6.08e-05	0.00184	CcSEcCtD
Vincristine—Neuropathy peripheral—Epirubicin—bone cancer	6.07e-05	0.00184	CcSEcCtD
Vincristine—Stomatitis—Epirubicin—bone cancer	6.04e-05	0.00183	CcSEcCtD
Vincristine—Dysuria—Doxorubicin—bone cancer	6.01e-05	0.00182	CcSEcCtD
Vincristine—Neutropenia—Doxorubicin—bone cancer	6.01e-05	0.00182	CcSEcCtD
Vincristine—Vinblastine—CYP3A4—bone cancer	5.97e-05	0.0202	CrCbGaD
Vincristine—Sweating—Epirubicin—bone cancer	5.94e-05	0.0018	CcSEcCtD
Vincristine—Urinary tract disorder—Methotrexate—bone cancer	5.87e-05	0.00178	CcSEcCtD
Vincristine—Photosensitivity reaction—Doxorubicin—bone cancer	5.87e-05	0.00178	CcSEcCtD
Vincristine—Urethral disorder—Methotrexate—bone cancer	5.83e-05	0.00176	CcSEcCtD
Vincristine—Weight decreased—Doxorubicin—bone cancer	5.82e-05	0.00176	CcSEcCtD
Vincristine—Pneumonia—Doxorubicin—bone cancer	5.77e-05	0.00175	CcSEcCtD
Vincristine—Hypersensitivity—Cisplatin—bone cancer	5.67e-05	0.00172	CcSEcCtD
Vincristine—Neuropathy peripheral—Doxorubicin—bone cancer	5.62e-05	0.0017	CcSEcCtD
Vincristine—Stomatitis—Doxorubicin—bone cancer	5.59e-05	0.00169	CcSEcCtD
Vincristine—Hypoaesthesia—Epirubicin—bone cancer	5.53e-05	0.00168	CcSEcCtD
Vincristine—Asthenia—Cisplatin—bone cancer	5.52e-05	0.00167	CcSEcCtD
Vincristine—Cardiac disorder—Methotrexate—bone cancer	5.52e-05	0.00167	CcSEcCtD
Vincristine—Sweating—Doxorubicin—bone cancer	5.5e-05	0.00166	CcSEcCtD
Vincristine—Urinary tract disorder—Epirubicin—bone cancer	5.49e-05	0.00166	CcSEcCtD
Vincristine—Connective tissue disorder—Epirubicin—bone cancer	5.47e-05	0.00165	CcSEcCtD
Vincristine—Urethral disorder—Epirubicin—bone cancer	5.45e-05	0.00165	CcSEcCtD
Vincristine—Angiopathy—Methotrexate—bone cancer	5.39e-05	0.00163	CcSEcCtD
Vincristine—Mediastinal disorder—Methotrexate—bone cancer	5.36e-05	0.00162	CcSEcCtD
Vincristine—Diarrhoea—Cisplatin—bone cancer	5.26e-05	0.00159	CcSEcCtD
Vincristine—Alopecia—Methotrexate—bone cancer	5.25e-05	0.00159	CcSEcCtD
Vincristine—Mental disorder—Methotrexate—bone cancer	5.21e-05	0.00158	CcSEcCtD
Vincristine—Cardiac disorder—Epirubicin—bone cancer	5.16e-05	0.00156	CcSEcCtD
Vincristine—Hypoaesthesia—Doxorubicin—bone cancer	5.12e-05	0.00155	CcSEcCtD
Vincristine—Urinary tract disorder—Doxorubicin—bone cancer	5.08e-05	0.00154	CcSEcCtD
Vincristine—Connective tissue disorder—Doxorubicin—bone cancer	5.06e-05	0.00153	CcSEcCtD
Vincristine—Angiopathy—Epirubicin—bone cancer	5.05e-05	0.00153	CcSEcCtD
Vincristine—Urethral disorder—Doxorubicin—bone cancer	5.04e-05	0.00153	CcSEcCtD
Vincristine—Mediastinal disorder—Epirubicin—bone cancer	5.01e-05	0.00152	CcSEcCtD
Vincristine—Back pain—Methotrexate—bone cancer	5e-05	0.00151	CcSEcCtD
Vincristine—Alopecia—Epirubicin—bone cancer	4.91e-05	0.00149	CcSEcCtD
Vincristine—Vomiting—Cisplatin—bone cancer	4.89e-05	0.00148	CcSEcCtD
Vincristine—Mental disorder—Epirubicin—bone cancer	4.87e-05	0.00147	CcSEcCtD
Vincristine—Rash—Cisplatin—bone cancer	4.85e-05	0.00147	CcSEcCtD
Vincristine—Dermatitis—Cisplatin—bone cancer	4.85e-05	0.00147	CcSEcCtD
Vincristine—Anaemia—Methotrexate—bone cancer	4.78e-05	0.00145	CcSEcCtD
Vincristine—Cardiac disorder—Doxorubicin—bone cancer	4.78e-05	0.00145	CcSEcCtD
Vincristine—Back pain—Epirubicin—bone cancer	4.68e-05	0.00142	CcSEcCtD
Vincristine—Angiopathy—Doxorubicin—bone cancer	4.67e-05	0.00141	CcSEcCtD
Vincristine—Vertigo—Methotrexate—bone cancer	4.65e-05	0.00141	CcSEcCtD
Vincristine—Mediastinal disorder—Doxorubicin—bone cancer	4.64e-05	0.0014	CcSEcCtD
Vincristine—Leukopenia—Methotrexate—bone cancer	4.63e-05	0.0014	CcSEcCtD
Vincristine—Nausea—Cisplatin—bone cancer	4.57e-05	0.00138	CcSEcCtD
Vincristine—Alopecia—Doxorubicin—bone cancer	4.55e-05	0.00138	CcSEcCtD
Vincristine—Mental disorder—Doxorubicin—bone cancer	4.51e-05	0.00136	CcSEcCtD
Vincristine—Convulsion—Methotrexate—bone cancer	4.48e-05	0.00136	CcSEcCtD
Vincristine—Anaemia—Epirubicin—bone cancer	4.47e-05	0.00135	CcSEcCtD
Vincristine—Agitation—Epirubicin—bone cancer	4.45e-05	0.00135	CcSEcCtD
Vincristine—Myalgia—Methotrexate—bone cancer	4.4e-05	0.00133	CcSEcCtD
Vincristine—Vertigo—Epirubicin—bone cancer	4.35e-05	0.00132	CcSEcCtD
Vincristine—Leukopenia—Epirubicin—bone cancer	4.33e-05	0.00131	CcSEcCtD
Vincristine—Back pain—Doxorubicin—bone cancer	4.33e-05	0.00131	CcSEcCtD
Vincristine—Anaphylactic shock—Methotrexate—bone cancer	4.22e-05	0.00128	CcSEcCtD
Vincristine—Convulsion—Epirubicin—bone cancer	4.19e-05	0.00127	CcSEcCtD
Vincristine—Infection—Methotrexate—bone cancer	4.19e-05	0.00127	CcSEcCtD
Vincristine—Hypertension—Epirubicin—bone cancer	4.18e-05	0.00127	CcSEcCtD
Vincristine—Nervous system disorder—Methotrexate—bone cancer	4.14e-05	0.00125	CcSEcCtD
Vincristine—Anaemia—Doxorubicin—bone cancer	4.14e-05	0.00125	CcSEcCtD
Vincristine—Thrombocytopenia—Methotrexate—bone cancer	4.13e-05	0.00125	CcSEcCtD
Vincristine—Myalgia—Epirubicin—bone cancer	4.12e-05	0.00125	CcSEcCtD
Vincristine—Agitation—Doxorubicin—bone cancer	4.12e-05	0.00125	CcSEcCtD
Vincristine—Hyperhidrosis—Methotrexate—bone cancer	4.08e-05	0.00124	CcSEcCtD
Vincristine—Vertigo—Doxorubicin—bone cancer	4.02e-05	0.00122	CcSEcCtD
Vincristine—Anorexia—Methotrexate—bone cancer	4.02e-05	0.00122	CcSEcCtD
Vincristine—Leukopenia—Doxorubicin—bone cancer	4.01e-05	0.00121	CcSEcCtD
Vincristine—Anaphylactic shock—Epirubicin—bone cancer	3.95e-05	0.0012	CcSEcCtD
Vincristine—Oedema—Epirubicin—bone cancer	3.95e-05	0.0012	CcSEcCtD
Vincristine—Hypotension—Methotrexate—bone cancer	3.95e-05	0.00119	CcSEcCtD
Vincristine—Infection—Epirubicin—bone cancer	3.93e-05	0.00119	CcSEcCtD
Vincristine—Convulsion—Doxorubicin—bone cancer	3.88e-05	0.00117	CcSEcCtD
Vincristine—Nervous system disorder—Epirubicin—bone cancer	3.87e-05	0.00117	CcSEcCtD
Vincristine—Thrombocytopenia—Epirubicin—bone cancer	3.87e-05	0.00117	CcSEcCtD
Vincristine—Hypertension—Doxorubicin—bone cancer	3.87e-05	0.00117	CcSEcCtD
Vincristine—TUBA4A—Metabolism of proteins—TUBB4B—bone cancer	3.87e-05	0.000668	CbGpPWpGaD
Vincristine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—bone cancer	3.85e-05	0.000665	CbGpPWpGaD
Vincristine—Musculoskeletal discomfort—Methotrexate—bone cancer	3.85e-05	0.00116	CcSEcCtD
Vincristine—Hyperhidrosis—Epirubicin—bone cancer	3.82e-05	0.00116	CcSEcCtD
Vincristine—Insomnia—Methotrexate—bone cancer	3.82e-05	0.00116	CcSEcCtD
Vincristine—Myalgia—Doxorubicin—bone cancer	3.81e-05	0.00115	CcSEcCtD
Vincristine—Paraesthesia—Methotrexate—bone cancer	3.79e-05	0.00115	CcSEcCtD
Vincristine—Anorexia—Epirubicin—bone cancer	3.77e-05	0.00114	CcSEcCtD
Vincristine—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.75e-05	0.000648	CbGpPWpGaD
Vincristine—Hypotension—Epirubicin—bone cancer	3.69e-05	0.00112	CcSEcCtD
Vincristine—Decreased appetite—Methotrexate—bone cancer	3.67e-05	0.00111	CcSEcCtD
Vincristine—Oedema—Doxorubicin—bone cancer	3.66e-05	0.00111	CcSEcCtD
Vincristine—Anaphylactic shock—Doxorubicin—bone cancer	3.66e-05	0.00111	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle, Mitotic—TUBB4B—bone cancer	3.65e-05	0.000631	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.65e-05	0.000631	CbGpPWpGaD
Vincristine—TUBB2B—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.65e-05	0.000631	CbGpPWpGaD
Vincristine—Gastrointestinal disorder—Methotrexate—bone cancer	3.65e-05	0.0011	CcSEcCtD
Vincristine—Fatigue—Methotrexate—bone cancer	3.64e-05	0.0011	CcSEcCtD
Vincristine—Infection—Doxorubicin—bone cancer	3.63e-05	0.0011	CcSEcCtD
Vincristine—Pain—Methotrexate—bone cancer	3.61e-05	0.00109	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Epirubicin—bone cancer	3.6e-05	0.00109	CcSEcCtD
Vincristine—Nervous system disorder—Doxorubicin—bone cancer	3.59e-05	0.00109	CcSEcCtD
Vincristine—Thrombocytopenia—Doxorubicin—bone cancer	3.58e-05	0.00108	CcSEcCtD
Vincristine—TUBB—Cell Cycle—RFC1—bone cancer	3.58e-05	0.000618	CbGpPWpGaD
Vincristine—Insomnia—Epirubicin—bone cancer	3.57e-05	0.00108	CcSEcCtD
Vincristine—Paraesthesia—Epirubicin—bone cancer	3.55e-05	0.00107	CcSEcCtD
Vincristine—Hyperhidrosis—Doxorubicin—bone cancer	3.53e-05	0.00107	CcSEcCtD
Vincristine—TUBB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.53e-05	0.000609	CbGpPWpGaD
Vincristine—Anorexia—Doxorubicin—bone cancer	3.48e-05	0.00105	CcSEcCtD
Vincristine—Gastrointestinal pain—Methotrexate—bone cancer	3.45e-05	0.00105	CcSEcCtD
Vincristine—Decreased appetite—Epirubicin—bone cancer	3.43e-05	0.00104	CcSEcCtD
Vincristine—Hypotension—Doxorubicin—bone cancer	3.42e-05	0.00103	CcSEcCtD
Vincristine—TUBB2A—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.41e-05	0.00059	CbGpPWpGaD
Vincristine—Gastrointestinal disorder—Epirubicin—bone cancer	3.41e-05	0.00103	CcSEcCtD
Vincristine—Fatigue—Epirubicin—bone cancer	3.41e-05	0.00103	CcSEcCtD
Vincristine—Constipation—Epirubicin—bone cancer	3.38e-05	0.00102	CcSEcCtD
Vincristine—Pain—Epirubicin—bone cancer	3.38e-05	0.00102	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—JUN—bone cancer	3.36e-05	0.00058	CbGpPWpGaD
Vincristine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.34e-05	0.000578	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	3.34e-05	0.000577	CbGpPWpGaD
Vincristine—TUBB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.34e-05	0.000577	CbGpPWpGaD
Vincristine—Body temperature increased—Methotrexate—bone cancer	3.34e-05	0.00101	CcSEcCtD
Vincristine—Abdominal pain—Methotrexate—bone cancer	3.34e-05	0.00101	CcSEcCtD
Vincristine—TUBA4A—Metabolism of proteins—TUBB2A—bone cancer	3.34e-05	0.000577	CbGpPWpGaD
Vincristine—Musculoskeletal discomfort—Doxorubicin—bone cancer	3.33e-05	0.00101	CcSEcCtD
Vincristine—TUBB2B—Metabolism of proteins—TUBB4B—bone cancer	3.32e-05	0.000573	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—TUBB4B—bone cancer	3.32e-05	0.000573	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—RFC1—bone cancer	3.31e-05	0.000572	CbGpPWpGaD
Vincristine—Insomnia—Doxorubicin—bone cancer	3.31e-05	0.001	CcSEcCtD
Vincristine—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.3e-05	0.00057	CbGpPWpGaD
Vincristine—Paraesthesia—Doxorubicin—bone cancer	3.28e-05	0.000994	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle—TUBB4B—bone cancer	3.27e-05	0.000564	CbGpPWpGaD
Vincristine—Gastrointestinal pain—Epirubicin—bone cancer	3.23e-05	0.000978	CcSEcCtD
Vincristine—TUBB3—Metabolism of proteins—TUBB4B—bone cancer	3.2e-05	0.000553	CbGpPWpGaD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	3.2e-05	0.000553	CbGpPWpGaD
Vincristine—Decreased appetite—Doxorubicin—bone cancer	3.18e-05	0.000962	CcSEcCtD
Vincristine—Gastrointestinal disorder—Doxorubicin—bone cancer	3.16e-05	0.000955	CcSEcCtD
Vincristine—Fatigue—Doxorubicin—bone cancer	3.15e-05	0.000954	CcSEcCtD
Vincristine—TUBB2B—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.15e-05	0.000544	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.15e-05	0.000544	CbGpPWpGaD
Vincristine—Pain—Doxorubicin—bone cancer	3.13e-05	0.000946	CcSEcCtD
Vincristine—Constipation—Doxorubicin—bone cancer	3.13e-05	0.000946	CcSEcCtD
Vincristine—Abdominal pain—Epirubicin—bone cancer	3.12e-05	0.000946	CcSEcCtD
Vincristine—Body temperature increased—Epirubicin—bone cancer	3.12e-05	0.000946	CcSEcCtD
Vincristine—Hypersensitivity—Methotrexate—bone cancer	3.11e-05	0.000942	CcSEcCtD
Vincristine—TUBB2A—Metabolism of proteins—TUBB4B—bone cancer	3.1e-05	0.000536	CbGpPWpGaD
Vincristine—TUBB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.04e-05	0.000526	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—TUBB4B—bone cancer	3.03e-05	0.000524	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—RFC1—bone cancer	3.03e-05	0.000523	CbGpPWpGaD
Vincristine—Asthenia—Methotrexate—bone cancer	3.03e-05	0.000917	CcSEcCtD
Vincristine—TUBB4A—Transmembrane transport of small molecules—TUBB4B—bone cancer	3e-05	0.000518	CbGpPWpGaD
Vincristine—Gastrointestinal pain—Doxorubicin—bone cancer	2.99e-05	0.000905	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle—RFC1—bone cancer	2.96e-05	0.000512	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—DHFR—bone cancer	2.92e-05	0.000504	CbGpPWpGaD
Vincristine—Hypersensitivity—Epirubicin—bone cancer	2.91e-05	0.000881	CcSEcCtD
Vincristine—Abdominal pain—Doxorubicin—bone cancer	2.89e-05	0.000875	CcSEcCtD
Vincristine—Body temperature increased—Doxorubicin—bone cancer	2.89e-05	0.000875	CcSEcCtD
Vincristine—Diarrhoea—Methotrexate—bone cancer	2.89e-05	0.000874	CcSEcCtD
Vincristine—TUBB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.88e-05	0.000498	CbGpPWpGaD
Vincristine—ABCC3—Fluoropyrimidine Activity—TP53—bone cancer	2.88e-05	0.000498	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—TUBB2A—bone cancer	2.86e-05	0.000495	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—TUBB2A—bone cancer	2.86e-05	0.000495	CbGpPWpGaD
Vincristine—ABCC3—NRF2 pathway—GSTP1—bone cancer	2.84e-05	0.000491	CbGpPWpGaD
Vincristine—ABCC3—NRF2 pathway—TGFBR2—bone cancer	2.84e-05	0.000491	CbGpPWpGaD
Vincristine—Asthenia—Epirubicin—bone cancer	2.83e-05	0.000858	CcSEcCtD
Vincristine—NR0B1—Gene Expression—NR1I2—bone cancer	2.83e-05	0.000489	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—SPARC—bone cancer	2.82e-05	0.000488	CbGpPWpGaD
Vincristine—Dizziness—Methotrexate—bone cancer	2.79e-05	0.000845	CcSEcCtD
Vincristine—TUBB3—Metabolism of proteins—TUBB2A—bone cancer	2.77e-05	0.000478	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—TUBB4B—bone cancer	2.72e-05	0.000471	CbGpPWpGaD
Vincristine—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	2.72e-05	0.00047	CbGpPWpGaD
Vincristine—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	2.71e-05	0.000468	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—RFC1—bone cancer	2.71e-05	0.000468	CbGpPWpGaD
Vincristine—Diarrhoea—Epirubicin—bone cancer	2.7e-05	0.000818	CcSEcCtD
Vincristine—Hypersensitivity—Doxorubicin—bone cancer	2.69e-05	0.000815	CcSEcCtD
Vincristine—Vomiting—Methotrexate—bone cancer	2.68e-05	0.000813	CcSEcCtD
Vincristine—Rash—Methotrexate—bone cancer	2.66e-05	0.000806	CcSEcCtD
Vincristine—Dermatitis—Methotrexate—bone cancer	2.66e-05	0.000805	CcSEcCtD
Vincristine—Headache—Methotrexate—bone cancer	2.64e-05	0.000801	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—EGFR—bone cancer	2.64e-05	0.000456	CbGpPWpGaD
Vincristine—Asthenia—Doxorubicin—bone cancer	2.62e-05	0.000794	CcSEcCtD
Vincristine—TUBB1—Metabolism of proteins—TUBB2A—bone cancer	2.62e-05	0.000452	CbGpPWpGaD
Vincristine—Dizziness—Epirubicin—bone cancer	2.61e-05	0.000791	CcSEcCtD
Vincristine—TUBA4A—Cell Cycle—DHFR—bone cancer	2.61e-05	0.00045	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.59e-05	0.000447	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—GNA11—bone cancer	2.58e-05	0.000446	CbGpPWpGaD
Vincristine—Vomiting—Epirubicin—bone cancer	2.51e-05	0.00076	CcSEcCtD
Vincristine—Nausea—Methotrexate—bone cancer	2.51e-05	0.000759	CcSEcCtD
Vincristine—Diarrhoea—Doxorubicin—bone cancer	2.5e-05	0.000757	CcSEcCtD
Vincristine—Rash—Epirubicin—bone cancer	2.49e-05	0.000754	CcSEcCtD
Vincristine—Dermatitis—Epirubicin—bone cancer	2.49e-05	0.000753	CcSEcCtD
Vincristine—TUBB—Cell Cycle, Mitotic—DHFR—bone cancer	2.48e-05	0.000428	CbGpPWpGaD
Vincristine—Headache—Epirubicin—bone cancer	2.48e-05	0.000749	CcSEcCtD
Vincristine—SLC22A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.43e-05	0.00042	CbGpPWpGaD
Vincristine—Dizziness—Doxorubicin—bone cancer	2.42e-05	0.000732	CcSEcCtD
Vincristine—TUBB4B—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.37e-05	0.000409	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—TUBB2A—bone cancer	2.35e-05	0.000406	CbGpPWpGaD
Vincristine—Nausea—Epirubicin—bone cancer	2.35e-05	0.00071	CcSEcCtD
Vincristine—TUBA4A—Hemostasis—IL3—bone cancer	2.34e-05	0.000404	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—EIF2S1—bone cancer	2.33e-05	0.000402	CbGpPWpGaD
Vincristine—Vomiting—Doxorubicin—bone cancer	2.32e-05	0.000704	CcSEcCtD
Vincristine—Rash—Doxorubicin—bone cancer	2.31e-05	0.000698	CcSEcCtD
Vincristine—Dermatitis—Doxorubicin—bone cancer	2.3e-05	0.000697	CcSEcCtD
Vincristine—Headache—Doxorubicin—bone cancer	2.29e-05	0.000693	CcSEcCtD
Vincristine—RALBP1—Signaling Pathways—RGS1—bone cancer	2.26e-05	0.00039	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GRM4—bone cancer	2.26e-05	0.00039	CbGpPWpGaD
Vincristine—ABCC2—NRF2 pathway—TGFBR2—bone cancer	2.25e-05	0.000389	CbGpPWpGaD
Vincristine—ABCC2—NRF2 pathway—GSTP1—bone cancer	2.25e-05	0.000389	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.24e-05	0.000386	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—DHFR—bone cancer	2.22e-05	0.000383	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CHEK2—bone cancer	2.18e-05	0.000376	CbGpPWpGaD
Vincristine—Nausea—Doxorubicin—bone cancer	2.17e-05	0.000657	CcSEcCtD
Vincristine—TUBB4B—Metabolism of proteins—TUBB2A—bone cancer	2.15e-05	0.000372	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.1e-05	0.000363	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—EIF2S1—bone cancer	2.09e-05	0.000362	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—DHFR—bone cancer	2.05e-05	0.000355	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—EIF2S1—bone cancer	2e-05	0.000345	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—EIF2S1—bone cancer	2e-05	0.000345	CbGpPWpGaD
Vincristine—CYP3A7—Biological oxidations—CYP3A4—bone cancer	1.99e-05	0.000344	CbGpPWpGaD
Vincristine—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	1.99e-05	0.000343	CbGpPWpGaD
Vincristine—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	1.96e-05	0.000339	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GRM1—bone cancer	1.96e-05	0.000339	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.93e-05	0.000333	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—EIF2S1—bone cancer	1.93e-05	0.000333	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—NDUFA12—bone cancer	1.9e-05	0.000328	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—DHFR—bone cancer	1.88e-05	0.000325	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—EIF2S1—bone cancer	1.87e-05	0.000323	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CHEK2—bone cancer	1.85e-05	0.00032	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—BRCA2—bone cancer	1.85e-05	0.000319	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—DHFR—bone cancer	1.84e-05	0.000317	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—EIF2S1—bone cancer	1.83e-05	0.000316	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—NDUFA12—bone cancer	1.82e-05	0.000315	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—EZH2—bone cancer	1.82e-05	0.000314	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.77e-05	0.000306	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.75e-05	0.000303	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—NDUFA12—bone cancer	1.75e-05	0.000302	CbGpPWpGaD
Vincristine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	1.75e-05	0.000302	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	1.73e-05	0.000299	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	1.73e-05	0.000298	CbGpPWpGaD
Vincristine—CYP3A7—Biological oxidations—GSTP1—bone cancer	1.7e-05	0.000294	CbGpPWpGaD
Vincristine—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	1.68e-05	0.00029	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—DHFR—bone cancer	1.68e-05	0.00029	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—EIF2S1—bone cancer	1.64e-05	0.000283	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—NT5C3A—bone cancer	1.58e-05	0.000272	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—BRCA2—bone cancer	1.57e-05	0.000271	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.54e-05	0.000266	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—PLAU—bone cancer	1.54e-05	0.000265	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CHEK2—bone cancer	1.54e-05	0.000265	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDK4—bone cancer	1.53e-05	0.000265	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.53e-05	0.000264	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.51e-05	0.000261	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—NT5C3A—bone cancer	1.51e-05	0.000261	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—EIF2S1—bone cancer	1.5e-05	0.000259	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—NT5C3A—bone cancer	1.45e-05	0.00025	CbGpPWpGaD
Vincristine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	1.44e-05	0.000249	CbGpPWpGaD
Vincristine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	1.42e-05	0.000245	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.42e-05	0.000245	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CHEK2—bone cancer	1.4e-05	0.000243	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SMO—bone cancer	1.38e-05	0.000238	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDK4—bone cancer	1.37e-05	0.000237	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NDUFA12—bone cancer	1.37e-05	0.000237	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—RB1—bone cancer	1.33e-05	0.00023	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.33e-05	0.00023	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDK4—bone cancer	1.3e-05	0.000225	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—BRCA2—bone cancer	1.3e-05	0.000225	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GNA11—bone cancer	1.26e-05	0.000218	CbGpPWpGaD
Vincristine—CYP3A5—Biological oxidations—GSTP1—bone cancer	1.23e-05	0.000213	CbGpPWpGaD
Vincristine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	1.21e-05	0.00021	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.21e-05	0.000208	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NDUFA12—bone cancer	1.2e-05	0.000208	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NDUFA12—bone cancer	1.19e-05	0.000206	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—RB1—bone cancer	1.19e-05	0.000206	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—BRCA2—bone cancer	1.19e-05	0.000206	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—ATF1—bone cancer	1.17e-05	0.000203	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDK4—bone cancer	1.16e-05	0.000201	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL3—bone cancer	1.14e-05	0.000198	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NT5C3A—bone cancer	1.13e-05	0.000196	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—RB1—bone cancer	1.13e-05	0.000196	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.1e-05	0.00019	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDK4—bone cancer	1.08e-05	0.000186	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MDM2—bone cancer	1.02e-05	0.000175	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—RB1—bone cancer	1.01e-05	0.000175	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.99e-06	0.000173	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NT5C3A—bone cancer	9.98e-06	0.000172	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NT5C3A—bone cancer	9.9e-06	0.000171	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDK4—bone cancer	9.87e-06	0.00017	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.86e-06	0.00017	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TGFBR2—bone cancer	9.79e-06	0.000169	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDK4—bone cancer	9.65e-06	0.000167	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—MMP2—bone cancer	9.52e-06	0.000164	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—RB1—bone cancer	9.38e-06	0.000162	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	9.34e-06	0.000161	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IGF1R—bone cancer	9.21e-06	0.000159	CbGpPWpGaD
Vincristine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.84e-06	0.000153	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDK4—bone cancer	8.83e-06	0.000152	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MDM2—bone cancer	8.63e-06	0.000149	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NDUFA12—bone cancer	8.63e-06	0.000149	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—RB1—bone cancer	8.58e-06	0.000148	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—RB1—bone cancer	8.39e-06	0.000145	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.35e-06	0.000144	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.33e-06	0.000144	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—MMP2—bone cancer	8.17e-06	0.000141	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—MMP2—bone cancer	8.17e-06	0.000141	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—MMP2—bone cancer	7.89e-06	0.000136	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—RB1—bone cancer	7.67e-06	0.000133	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—MMP2—bone cancer	7.64e-06	0.000132	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—MMP2—bone cancer	7.47e-06	0.000129	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.19e-06	0.000124	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MDM2—bone cancer	7.15e-06	0.000124	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NT5C3A—bone cancer	7.15e-06	0.000124	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ENO2—bone cancer	6.9e-06	0.000119	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—MMP2—bone cancer	6.71e-06	0.000116	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KIT—bone cancer	6.68e-06	0.000115	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ENO2—bone cancer	6.62e-06	0.000114	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MDM2—bone cancer	6.54e-06	0.000113	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NDUFA12—bone cancer	6.51e-06	0.000113	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—DHFR—bone cancer	6.4e-06	0.000111	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ENO2—bone cancer	6.34e-06	0.00011	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—BRAF—bone cancer	6.28e-06	0.000108	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.2e-06	0.000107	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—bone cancer	6.17e-06	0.000107	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—DHFR—bone cancer	6.14e-06	0.000106	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—MMP2—bone cancer	6.14e-06	0.000106	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GNA11—bone cancer	5.98e-06	0.000103	CbGpPWpGaD
Vincristine—ABCC1—Disease—ENO2—bone cancer	5.93e-06	0.000102	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—DHFR—bone cancer	5.88e-06	0.000102	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—bone cancer	5.83e-06	0.000101	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GNA11—bone cancer	5.74e-06	9.91e-05	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.73e-06	9.89e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.65e-06	9.76e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—DHFR—bone cancer	5.5e-06	9.51e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GNA11—bone cancer	5.5e-06	9.5e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CYP3A4—bone cancer	5.42e-06	9.37e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NT5C3A—bone cancer	5.4e-06	9.32e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MDM2—bone cancer	5.26e-06	9.09e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CYP3A4—bone cancer	5.2e-06	8.98e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.17e-06	8.94e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CYP3A4—bone cancer	4.99e-06	8.61e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ENO2—bone cancer	4.97e-06	8.58e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.96e-06	8.57e-05	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—bone cancer	4.95e-06	8.56e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GSTP1—bone cancer	4.64e-06	8.01e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—DHFR—bone cancer	4.61e-06	7.96e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.59e-06	7.93e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—JUN—bone cancer	4.57e-06	7.9e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MMP9—bone cancer	4.45e-06	7.69e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GSTP1—bone cancer	4.45e-06	7.68e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.43e-06	7.65e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ENO2—bone cancer	4.37e-06	7.55e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ENO2—bone cancer	4.33e-06	7.49e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GNA11—bone cancer	4.31e-06	7.44e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GSTP1—bone cancer	4.26e-06	7.37e-05	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—bone cancer	4.1e-06	7.09e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—DHFR—bone cancer	4.06e-06	7.01e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—DHFR—bone cancer	4.02e-06	6.95e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NDUFA12—bone cancer	4.01e-06	6.93e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.99e-06	6.9e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—TGFBR2—bone cancer	3.99e-06	6.89e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP3A4—bone cancer	3.91e-06	6.75e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.89e-06	6.71e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GNA11—bone cancer	3.79e-06	6.55e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GNA11—bone cancer	3.76e-06	6.49e-05	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—bone cancer	3.75e-06	6.48e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EGFR—bone cancer	3.6e-06	6.21e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP3A4—bone cancer	3.44e-06	5.94e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP3A4—bone cancer	3.41e-06	5.89e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GSTP1—bone cancer	3.34e-06	5.77e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NT5C3A—bone cancer	3.33e-06	5.74e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.14e-06	5.42e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ENO2—bone cancer	3.13e-06	5.41e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—bone cancer	3.02e-06	5.22e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GSTP1—bone cancer	2.94e-06	5.08e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GSTP1—bone cancer	2.91e-06	5.03e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—DHFR—bone cancer	2.91e-06	5.02e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—KIT—bone cancer	2.72e-06	4.7e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GNA11—bone cancer	2.72e-06	4.69e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.64e-06	4.55e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—BRAF—bone cancer	2.56e-06	4.42e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP3A4—bone cancer	2.46e-06	4.25e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—bone cancer	2.4e-06	4.15e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ENO2—bone cancer	2.36e-06	4.08e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—bone cancer	2.3e-06	3.98e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—bone cancer	2.21e-06	3.82e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—DHFR—bone cancer	2.19e-06	3.79e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MDM2—bone cancer	2.14e-06	3.7e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GSTP1—bone cancer	2.11e-06	3.64e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—bone cancer	2.07e-06	3.57e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GNA11—bone cancer	2.05e-06	3.54e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP3A4—bone cancer	1.86e-06	3.21e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—bone cancer	1.73e-06	2.99e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTP1—bone cancer	1.59e-06	2.75e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—bone cancer	1.52e-06	2.63e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—bone cancer	1.51e-06	2.61e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGFR—bone cancer	1.47e-06	2.53e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ENO2—bone cancer	1.46e-06	2.52e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—DHFR—bone cancer	1.35e-06	2.33e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GNA11—bone cancer	1.26e-06	2.18e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—bone cancer	1.09e-06	1.88e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTP1—bone cancer	9.79e-07	1.69e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—bone cancer	8.23e-07	1.42e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—bone cancer	5.07e-07	8.76e-06	CbGpPWpGaD
